SCHEMBL30675634

SCHEMBL30675634

COc1c(C)cccc1C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.70
KDM4E B2RXH2 2/20 0.70
HPGD P15428 2/20 0.70
HSD17B10 Q99714 2/20 0.70
MYC P01106 1/20 0.53
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
KMT2A Q03164 2/20 0.50
MAPK1 P28482 1/20 0.50
POLB P06746 1/20 0.49
CASR P41180 1/20 0.48
TDP1 Q9NUW8 2/20 0.47
MEN1 O00255 1/20 0.47
AKR1B10 O60218 1/20 0.47
TRPA1 O75762 1/20 0.47
ABCB11 O95342 1/20 0.47
DHFR P00374 1/20 0.47
LMNA P02545 1/20 0.47
MPO P05164 1/20 0.47
CYP1A2 P05177 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL305252 1.00 ALDH1A1 (0.70) ALDH1A1KDM4EHPGDHSD17B10MYC
SCHEMBL9183165 0.98 ALDH1A1 (0.68) ALDH1A1KDM4EHPGDHSD17B10MYC
Bicarbonate SCHEMBL4612198 0.98 ALDH1A1 (0.68) ALDH1A1KDM4EHPGDHSD17B10MYC
SCHEMBL28496827 0.98 ALDH1A1 (0.68) ALDH1A1KDM4EHPGDHSD17B10MYC
Boric Acid SCHEMBL25416181 0.96 ALDH1A1 (0.66) ALDH1A1KDM4EHPGDHSD17B10MYC
SCHEMBL28657558 0.91 KDM4E (0.60) ALDH1A1KDM4EHPGDHSD17B10MYC
SCHEMBL39857 0.89 ALDH1A1 (0.55) ALDH1A1KDM4EHPGDHSD17B10MAPK1
Hydrochloric Acid SCHEMBL699717 0.87 ALDH1A1 (0.53) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL32674573 0.86 MYC (0.57) ALDH1A1KDM4EHPGDHSD17B10MYC
SCHEMBL9726590 0.85 KDM4E (0.52) ALDH1A1KDM4EHPGDHSD17B10MYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630549-B2 Pyrazoleamide derivatives HOFFMANN-LA ROCHE INC. (US) 2026-05-19 US disclosed
US-20230382911-A1 PYRAZOLEAMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2023-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382911-A1 PYRAZOLEAMIDE DERIVATIVES P2RY1, P2RX1, P2RX5 ALDH1A1 203/4885KDM4E 2850/4885HPGD 611/4885
US-12630549-B2 Pyrazoleamide derivatives CYP11B2, CYP11B1, ADRA1B ALDH1A1 439/4885KDM4E 3127/4885HPGD 1203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.